ResearcherCentre National de la Recherche ScientifiqueNo recent work listed
Julie Leca
Matched on ORCID iD 0000-0002-6592-0698; OpenAlex author ID A5081436672. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers
Papers 7
- CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness. First author DOI 10.1126/scisignal.abg8191↗
- Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. Co-author DOI 10.15252/embj.2021110466↗
- LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. Co-author DOI 10.1158/0008-5472.can-15-2790↗
- TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/cdd.2016.18↗
- Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. Co-author DOI 10.1172/jci87734↗
- Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling. First author DOI 10.1038/cddis.2014.557↗
- Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. First author DOI 10.1073/pnas.1219555110↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sophie Vasseur · 7 shared papers, 2013–2022 · strength 0.48
- Paper CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cel… DOI 10.1126/scisignal.abg8191↗
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. DOI 10.1158/0008-5472.can-15-2790↗
- Richard Tomasini · 7 shared papers, 2013–2022 · strength 0.48
- Paper CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cel… DOI 10.1126/scisignal.abg8191↗
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. DOI 10.1158/0008-5472.can-15-2790↗
- Juan Iovanna · 7 shared papers, 2013–2022 · strength 0.48
- Paper CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cel… DOI 10.1126/scisignal.abg8191↗
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. DOI 10.1158/0008-5472.can-15-2790↗
- Jérémy Nigri · 6 shared papers, 2015–2022 · strength 0.45
- Paper CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cel… DOI 10.1126/scisignal.abg8191↗
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. DOI 10.1158/0008-5472.can-15-2790↗
- Fabienne Guillaumond · 6 shared papers, 2013–2022 · strength 0.44
- Paper CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cel… DOI 10.1126/scisignal.abg8191↗
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. DOI 10.1158/0008-5472.can-15-2790↗
- François Bertucci · 2 shared papers, 2022 · strength 0.25
- Nelson Dusetti · 4 shared papers, 2013–2022 · strength 0.23
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. DOI 10.1172/jci87734↗
- Paper Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling. DOI 10.1038/cddis.2014.557↗
- Christian Bressy · 4 shared papers, 2015–2018 · strength 0.20
- Paper LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. DOI 10.1158/0008-5472.can-15-2790↗
- Paper TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. DOI 10.1038/cdd.2016.18↗
- Paper Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. DOI 10.1172/jci87734↗
- Sébastien Martinez · 2 shared papers, 2016–2022 · strength 0.18
- Véronique Secq · 3 shared papers, 2015–2018 · strength 0.15
- Paper LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. DOI 10.1158/0008-5472.can-15-2790↗
- Paper Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. DOI 10.1172/jci87734↗
- Paper Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling. DOI 10.1038/cddis.2014.557↗
- Mehdi Ouaïssi · 3 shared papers, 2015–2018 · strength 0.15
- Paper LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. DOI 10.1158/0008-5472.can-15-2790↗
- Paper Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. DOI 10.1172/jci87734↗
- Paper Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling. DOI 10.1038/cddis.2014.557↗
- Evan Chen Lien · 1 shared paper, 2022 · strength 0.11
- Tristan Gicquel · 1 shared paper, 2022 · strength 0.11
- Victoire Gouirand · 1 shared paper, 2022 · strength 0.11
- Emilie Jaune · 1 shared paper, 2022 · strength 0.11
- Jared R. Mayers · 1 shared paper, 2022 · strength 0.11
- Matthew G. Vander Heiden · 1 shared paper, 2022 · strength 0.11
- Julie Roques · 2 shared papers, 2016–2018 · strength 0.11
- Daniel Pietrasz · 2 shared papers, 2016–2018 · strength 0.11
- Jean‐Baptiste Bachet · 2 shared papers, 2016–2018 · strength 0.11
- A K Thakur · 2 shared papers, 2015–2016 · strength 0.09
- Corinne Bousquet · 2 shared papers, 2015–2016 · strength 0.08
- Céline Loncle · 2 shared papers, 2013–2016 · strength 0.07
- Laurent Bartholin · 1 shared paper, 2016 · strength 0.05
- Olivıer Turrini · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.